ProMIS Neurosciencesの内部者の所有権
ProMIS Neurosciencesの内部者の所有権は何ですか。
ProMIS Neurosciences, Inc.の内部者の所有権は10.14%です。
内部者の所有権の定義は何ですか。
管理の所有権(Insider Ownership)は、発行済株式総数で除したインサイダー（5％超を所有する株主または取締役または役員) が所有する株式総数によって計算されます。
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
TSXのセクタHealth Careにおける内部者の所有権の企業と比べるProMIS Neurosciences
ProMIS Neurosciencesは何をしますか。
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
ProMIS Neurosciencesと類似の内部者の所有権
- Galiano Goldの内部者の所有権は10.12%です。
- The North American Income Trust Plcの内部者の所有権は10.12%です。
- Universal Insurance Incの内部者の所有権は10.13%です。
- Western Alaska Minerals Corpの内部者の所有権は10.13%です。
- Spectrum Pharmaceuticalsの内部者の所有権は10.14%です。
- Nearmap Ltdの内部者の所有権は10.14%です。
- ProMIS Neurosciencesの内部者の所有権は10.14%です。
- Conquest Resourcesの内部者の所有権は10.15%です。
- Nephrosの内部者の所有権は10.15%です。
- Nephrosの内部者の所有権は10.15%です。
- Nephrosの内部者の所有権は10.15%です。
- Nephrosの内部者の所有権は10.15%です。
- Nephrosの内部者の所有権は10.15%です。